8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2002 / Intervention study (replication trial)
This study evaluated the weight losses and attrition rates of 128 participants in three satellite groups of the Trevose Behavior Modification Program. Mean intent-to-treat weight loss across all participants was 13.7 +/- 0.7% of initial body weight (1.8 +/- 0.7 kg). At two years, 43.8% of participants remained in treatment with a mean loss of 19.0 +/- 0.8% of body weight (16.2 +/- 1.0 kg), and at five years, 23.4% remained with a mean loss of 18.4 +/- 1.1% of body weight (15.6 +/- 1.5 kg).
Latner JD, Wilson GT, Stunkard AJ, et al. Behav Res Ther, 2002. PMID 12074374
2002 / Counterbalanced within-subjects trial
Thirty severely obese youngsters undergoing a 10-month residential treatment completed treadmill tests to exhaustion across four counterbalanced sessions (with music vs. without music) at the beginning and end of treatment. Obese youngsters ran significantly longer during the distraction condition, an effect that appeared larger at the start compared to the end of treatment. There were no differences in perceived bodily symptoms between conditions, while physiological data indicated superior peak performance during distraction.
De Bourdeaudhuij I, Crombez G, Deforche B, et al. Int J Obes Relat Metab Disord, 2002. PMID 12119566
2002 / Crossover trial
Twenty-four healthy, lean men and women underwent two 2-day treatments: a 36-hour fast or a maintenance diet, followed by a day of ad libitum feeding. On the ad libitum day, average energy intake was 12.2 MJ/day after fasting compared to 10.2 MJ/day after maintenance (P=0.049). Feeding behaviour shifted only at breakfast, where participants selected a higher-fat meal (P<0.005). Motivation to eat increased during the fast compared to baseline (P<0.05) and returned to baseline after breakfast on the re-feeding day.
Johnstone AM, Faber P, Gibney ER, et al. Int J Obes Relat Metab Disord, 2002. PMID 12461679
2002 / Laboratory experiment (2x2x2 factorial design)
An experiment with a 2 (restrained/unrestrained) x 2 (distraction yes/no) x 2 (perceived calories high/low) design evaluated ice-cream consumption in a taste test setting. A significant interaction was found: in the high-calorie condition, restrained eaters ate the same amount as unrestrained eaters when not distracted, but considerably more when distracted. Additionally, an unexpected main effect showed that both restrained and unrestrained eaters consumed more ice cream when distracted than when not distracted.
Boon B, Stroebe W, Schut H, et al. Br J Health Psychol, 2002. PMID 14596713
2001 / Randomized controlled trial
A 6-month randomized trial evaluated 27 obese postmenopausal women assigned to moderate energy restriction or weight maintenance. In the weight-loss group, body weight decreased by 10.2 +/- 5.5% and total-body bone mineral density fell by 1.2 +/- 1.2%, differing significantly from controls (P < 0.05). Energy-restricted women also demonstrated chronically elevated markers of bone resorption and formation compared to weight maintainers (P < 0.05).
Ricci TA, Heymsfield SB, Pierson RN, et al. Am J Clin Nutr, 2001. PMID 11157334
2001 / Randomized controlled trial
In an 8-week trial, 67 overweight adults were randomized to receive placebo or an herbal formula providing daily amounts of 72 mg ephedrine alkaloids plus 240 mg caffeine. Active treatment resulted in greater weight loss (-4.0 +/- 3.4 kg vs. -0.8 +/- 2.4 kg) and body fat reduction (-2.1 +/- 3.0% vs. 0.2 +/- 2.3%). However, 23% of actively treated participants withdrew due to potential adverse effects, including dry mouth, insomnia, and headache.
Boozer CN, Nasser JA, Heymsfield SB, et al. Int J Obes Relat Metab Disord, 2001. PMID 11319627
2001 / Randomized controlled trial
A one-year behavioral program randomized families with an obese parent and non-obese child to emphasize either higher fruit and vegetable consumption or reduced high-fat and high-sugar intake. Both treatments altered the targeted child and parent eating behaviors, and the fruit and vegetable group also lowered high-fat and high-sugar intake. Parents in the increased fruit and vegetable arm achieved significantly greater drops in percentage of overweight.
Epstein LH, Gordy CC, Raynor HA, et al. Obes Res, 2001. PMID 11323442
2001 / Randomized controlled trial
A randomized trial assigned 522 overweight adults with impaired glucose tolerance to an individualized diet and exercise intervention or a control group for a mean follow-up of 3.2 years. The intervention group lost significantly more weight than controls at year one (4.2 vs. 0.8 kg) and year two (3.5 vs. 0.8 kg; p < 0.001). The cumulative four-year diabetes incidence was 11% (95% CI, 6-15%) with intervention versus 23% (95% CI, 17-29%) in controls, representing a 58% risk reduction (p < 0.001).
Tuomilehto J, Lindström J, Eriksson JG, et al. N Engl J Med, 2001. PMID 11333990
2001 / Repeated-measures laboratory feeding trial (4 conditions)
Forty-one healthy women completed once-weekly ad libitum laboratory lunches under 4 conditions: alone (baseline), focused on food sensory aspects (attention), listening to a detective story (distraction), and eating in a group of 4. Meal size was significantly higher during distraction than baseline (by 301 +/- 26 kJ; P < 0.001). The energy intake increase from baseline to distraction correlated significantly with cognitive restraint (factor 1 of the TFEQ; r = 0.51, P < 0.01), with meal size increasing by 50 kJ per additional factor 1 point. Group eating did not increase meal size.
Bellisle F, Dalix AM Am J Clin Nutr, 2001. PMID 11470720
2001 / Pre-post intervention study with a cross-sectional comparison group
Fasting serum was collected from 13 overweight men before and after an 11-day low-fat, high-fiber diet and exercise intervention, and from 8 men who adhered to the regimen for an average of 14.2 years. Post-intervention serum from the 11-day group reduced LNCaP cell growth by a mean of 30% compared with pre-intervention serum (p < 0.01), and serum from long-term subjects reduced growth by an additional 15% (p < 0.01). PC-3 cell growth did not differ between serum groups. In the 11-day subjects, body weight, serum free testosterone, glucose, and lipids were significantly reduced.
Tymchuk CN, Barnard RJ, Heber D, et al. J Urol, 2001. PMID 11490320
2001 / Randomized controlled trial (2x2 factorial design)
Seventy-five obese adults with clear treatment preferences were randomly assigned to either preferred or nonpreferred treatment across individual versus group therapy for obesity. At posttreatment, group therapy led to significantly greater reductions in weight and body mass compared to individual therapy. Treatment preference and the interaction between preference and therapy type had no significant effects, while psychological functioning improved equivalently across all conditions.
Renjilian DA, Perri MG, Nezu AM, et al. J Consult Clin Psychol, 2001. PMID 11550739
2001 / Clinical trial
Eighty-four adults consumed 325-ml (220 kcal) shakes matched for nutrients and volume at weekly intervals with differing thickness. The thicker shake elicited significantly larger and more sustained decreases in hunger over four hours. However, no significant differences appeared in the timing or size of the subsequent meal, nor in total 24-hour caloric intake.
Mattes RD, Rothacker D Physiol Behav, 2001. PMID 11790415
2000 / Interventional study
Sixteen patients with plurimetabolic syndrome were evaluated before and during a 16-day medically controlled severe underfeeding regimen (230 kcal/day) at rest and in response to exercise. Mean resting norepinephrine decreased from 1.45 to 0.96 nmol/liter, and exercise-induced norepinephrine decreased from 6.1 to 3.2 nmol/liter. Resting epinephrine decreased from 0.15 to 0.1 nmol/liter, and exercise-induced epinephrine fell from 0.26 to 0.17 nmol/liter. A significant decrease in catecholamine concentrations was observed after 16 days, although most of the fall in mean norepinephrine and blood pressure occurred by Day 2.
Göhler L, Hahnemann T, Michael N, et al. Prev Med, 2000. PMID 10656837
2000 / Crossover trial
In a crossover study, 33 women followed a low-fat, vegetarian diet for two menstrual cycles and their customary diet while taking a placebo pill for two cycles. Serum sex-hormone binding globulin was significantly higher during the diet phase (46.7 +/- 23.6 nmol/L) than the supplement phase (39.3 +/- 19.8 nmol/L, P < .001), and body weight was lower (66.1 +/- 11.3 kg vs 67.9 +/- 12.1 kg, P < .001). Mean dysmenorrhea duration dropped from baseline (3.9 +/- 1.7 days) to diet phase (2.7 +/- 1.9 days) compared to the supplement phase change (3.6 +/- 1.7 days, P < .01). Pain intensity and durations of premenstrual concentration, behavioral change, and water retention symptoms were also significantly reduced.
Barnard ND, Scialli AR, Hurlock D, et al. Obstet Gynecol, 2000. PMID 10674588
2000 / Intervention trial with two energy-deficit groups
Healthy young men in an 8-week US Army Ranger course experienced repeated cycles of energy restriction and refeeding with average energy deficits of 1,200 kcal/day (group 1) or 1,000 kcal/day (group 2). In group 1, 8 weeks led to serum T3 below normal (78 +/- 20 ng/dl), testosterone near castrate levels (4.5 +/- 3.9 nmol/l), IGF-I halved (75 +/- 25 microg/l), and cholesterol increased from 158 +/- 31 to 217 +/- 39 mg/dl. Refeeding prompted rapid recovery of T3, testosterone, and IGF-I even as other stressors continued. Higher energy intake in group 2 attenuated subclinical hypothyroidism and hypercholesterolemia.
Friedl KE, Moore RJ, Hoyt RW, et al. J Appl Physiol (1985), 2000. PMID 10797147
2000 / Crossover study
Fifteen adults received 1,880 kJ daily of carbohydrate as either soda or jelly beans across two four-week phases separated by a four-week washout. During the solid phase, participants achieved precise caloric compensation of 118%. Conversely, liquid consumption yielded negative compensation (-17%), resulting in elevated total daily energy intake along with significant gains in body weight and body mass index.
DiMeglio DP, Mattes RD Int J Obes Relat Metab Disord, 2000. PMID 10878689
2000 / Controlled clinical trial
Researchers evaluated 1 week of creatine supplementation in vegetarians and meat-eaters, alongside a control group of meat-eaters given glucose. Creatine ingestion increased body mass by about 1 kg and mean power output by roughly 5% in both vegetarian and meat-eating groups (P < 0.05-0.001). Peak power output rose significantly only in meat-eaters taking creatine (~5%, P < 0.05), whereas the glucose control group experienced no performance changes.
Shomrat A, Weinstein Y, Katz A Eur J Appl Physiol, 2000. PMID 10958375
2000 / Controlled trial
Healthy obese and matched lean control subjects received either whole-body ultraviolet radiation or an oral dose of 50,000 IU (1.25 mg) vitamin D2. Obese subjects had significantly lower basal 25-hydroxyvitamin D and higher parathyroid hormone concentrations. The incremental increase in blood vitamin D3 24 h after irradiation was 57% lower in obese subjects, despite similar skin 7-dehydrocholesterol content and in vitro conversion. BMI was inversely correlated with serum vitamin D3 concentrations after irradiation (r = -0.55, P = 0.003) and peak serum vitamin D2 concentrations after oral intake (r = -0.56, P = 0.007).
Wortsman J, Matsuoka LY, Chen TC, et al. Am J Clin Nutr, 2000. PMID 10966885
2000 / Intervention study with non-randomized control group
Thirty-nine obese individuals followed a hypocaloric diet for 15 weeks, with blood and subcutaneous adipose tissue analysed before and after treatment for 26 organochlorine compounds, alongside a control group of 57 women. Following treatment (mean body weight loss 9.5 kg), all 19 detected compounds increased in plasma concentration, 15 of which were statistically significant; 5 increased significantly compared to controls. These increases persisted after an 18-week low-fat diet/exercise follow-up, correlated with weight loss (-0.3 >= r >= -0.6, P<0.05), and were also observed in subcutaneous adipose tissue.
Chevrier J, Dewailly E, Ayotte P, et al. Int J Obes Relat Metab Disord, 2000. PMID 11093288
2000 / Open, non-randomized controlled study
An open, non-randomized controlled trial evaluated the effects of a 3-month strict, low-salt, uncooked vegan diet rich in lactobacteria in 18 fibromyalgia patients compared to 15 omnivorous controls. Significant improvements in the intervention group were found for pain VAS (p=0.005), joint stiffness (p=0.001), quality of sleep (p=0.0001), HAQ (p=0.031), GHQ (p=0.021), and a rheumatologist's questionnaire (p=0.038). Shifting to the vegan diet also significantly lowered BMI (p=0.0001) and total serum cholesterol (p=0.003), while urine sodium decreased to 1/3 of baseline values (p=0.0001).
Kaartinen K, Lammi K, Hypen M, et al. Scand J Rheumatol, 2000. PMID 11093597
1999 / Crossover trial
Twelve obese teenage boys consumed low-, medium-, or high-glycemic-index test meals at breakfast and lunch during three crossover evaluations. Subsequent voluntary energy intake over five hours was 5.8 mJ after the high-glycemic meal, which was 53% higher than following the medium-glycemic meal (3.8 mJ) and 81% higher than after the low-glycemic meal (3.2 mJ). The high-glycemic meal also produced higher insulin, lower glucagon, lower postabsorptive glucose and fatty acids, and elevated epinephrine.
Ludwig DS, Majzoub JA, Al-Zahrani A, et al. Pediatrics, 1999. PMID 10049982
1999 / Crossover trial
Nine healthy men were evaluated under four conditions on different days: eating a 2582 kJ meal, sensory stimulation with the meal (seeing, smelling, tasting), non-alimentary sensory stimulation, and intragastric tube feeding of the meal. Energy expenditure changes over midday rest were +12.0% for the meal, +3.2% for alimentary stimulation, -2.6% for non-alimentary stimulation, and +5.7% for tube feeding. The energy expenditure rise was significantly higher following the meal than after sensory stimulation alone or tube feeding (both P < 0.01). Furthermore, the increase in energy expenditure correlated negatively with BMI only after alimentary sensory stimulation (r = -0.700; P < 0.05).
Brondel L, Fricker J, Fantino M Int J Obes Relat Metab Disord, 1999. PMID 10094574
1999 / Randomized crossover trial
In a randomized crossover trial, 10 healthy adults were given 50 mg of ephedrine or placebo three times daily in a calorimeter. Ephedrine increased 24-hour energy expenditure by 3.6% compared to placebo (8965+/-1301 versus 8648+/-1347 kJ, P<0.05). Mechanical work did not differ between periods, but urinary noradrenaline excretion was significantly lower with ephedrine (0.032+/-0.011 versus 0.044+/-0.012 microg/mg creatinine, P<0.05).
Shannon JR, Gottesdiener K, Jordan J, et al. Clin Sci (Lond), 1999. PMID 10209080
1999 / Double-blind, placebo-controlled trial
Sixteen healthy male volunteers received graded intravenous doses (0, 0.375, 0.75, and 1.5 pmol/kg/min) of synthetic human GLP-1 in a double-blind, placebo-controlled setup. Graded GLP-1 infusions caused a dose-dependent reduction in food intake (maximal inhibition 35%, p<0.001 vs control), calorie intake (32% reduction, p<0.001), and fluid ingestion (18% reduction, p<0.01). At the highest dose, participants reported less hunger and early fullness prior to a meal (p<0.05), with no overt side effects observed.
Gutzwiller JP, Göke B, Drewe J, et al. Gut, 1999. PMID 9862830